Logo image
Induction immunosuppression and the risk of incident malignancies among older and younger kidney transplant recipients: A prospective cohort study
Journal article   Open access   Peer reviewed

Induction immunosuppression and the risk of incident malignancies among older and younger kidney transplant recipients: A prospective cohort study

Lingyu Wang, Jennifer Motter, Sunjae Bae, JiYoon B. Ahn, Jennifer A. Kanakry, John Jackson, Mark A. Schnitzler, Gregory Hess, Krista L. Lentine, Elizabeth A. Stuart, …
Clinical transplantation, v 34(12), 14121
Dec 2020
PMID: 33048385
url
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503780View
Accepted (AM) Open PubMed Central

Abstract

Life Sciences & Biomedicine Science & Technology Transplantation Surgery
Background: Older (>= 65) KT recipients differ from their younger counterparts in their immune response to immunosuppression (IS) and may have a different risk of malignancy after receiving induction. Methods: We identified 66 700 adult KT recipients treated with anti-thymocyte globulin (ATG) (n = 40 443) or interleukin-2 receptor antagonist (IL-2RA) (n = 26 327) induction (1/1/1999-12/31/2014) using USRDS/Medicare data. We estimated the risk of first-diagnosed post-KT malignancy associated with induction (ATG vs. IL-2RA) using Cox proportional hazard models. We then tested whether these risks differed between older and younger recipients (Wald test for interaction). Models incorporated inverse probability of treatment weights to adjust for confounders. Results: The 3-year cumulative incidences of any diagnosed malignancy were 11.5%. ATG was associated with a higher malignancy risk (HR = 1.12, 95%CI:1.06-1.18). This association differed (p(interaction) = 0.04) between younger (HR = 1.12, 95%CI:1.06-1.18) and older recipients (HR = 1.03, 95%CI:0.96-1.09). ATG was also associated with higher risk of skin (HR = 1.18, 95%CI:1.08-1.29), lung (HR = 1.24, 95%CI:1.05-1.47), and ovary malignancies (HR = 1.94, 95%CI:1.08-3.48). However, only the association of ATG with post-KT skin malignancy differed (p(interaction) = 0.01) between younger (HR = 1.18; 95%CI:1.08-1.29) and older (HR = 1.01; 95%CI:0.93-1.09) recipients. Conclusions: Compared with IL-2RA induction, ATG was associated with elevated post-KT malignancy risk but only among younger recipients. Transplant centers may need to tailor induction IS for younger recipients to mitigate malignancy risk.

Metrics

10 Record Views
12 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Surgery
Transplantation
Logo image